Log on / register
Feedback | Support | My details
Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer.
Stewart DA, Cooper CR, Sikes RA
Reprod Biol Endocrinol 2004 Jan 7, 2:2
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
Pulukuri SM, Estes N, Patel J, Rao JS
Cancer Res 2007 Feb 1, 67:930-9
[PubMed Central] [PubMed] [Related articles]

2.
Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.
Pulukuri SM, Gorantla B, Rao JS
J Biol Chem 2007 Dec 7, 282:35594-603
[PubMed Central] [PubMed] [Related articles]

3.
Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis.
Dean JP, Nelson PS
Br J Cancer 2008 Jan 29, 98:245-9
[PubMed Central] [PubMed] [Related articles]

4.
Mechanics, malignancy, and metastasis: the force journey of a tumor cell.
Kumar S, Weaver VM
Cancer Metastasis Rev 2009 Jun, 28:113-27
[PubMed Central] [PubMed] [Related articles]

5.
Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
McCabe NP, De S, Vasanji A, Brainard J, Byzova TV
Oncogene 2007 Sep 13, 26:6238-43
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 4 articles in BioMed Central

printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.